How do different forms of CBD (e.g., isolate, full-spectrum) affect its pharmacological properties and therapeutic outcomes?
How do different forms of CBD (e.g., isolate, full-spectrum) affect its pharmacological properties and therapeutic outcomes? Different forms of CBD, such as isolate, broad-spectrum, and full-spectrum, exhibit varying pharmacological properties and therapeutic outcomes due to their distinct cannabinoid and terpene profiles. CBD isolate, which contains only CBD, may lack the synergistic effects provided by other cannabinoids and terpenes found in full-spectrum products, potentially limiting its therapeutic efficacy. Full-spectrum products, containing a wider array of cannabinoids, terpenes, and flavonoids, may benefit from the entourage effect, enhancing overall therapeutic outcomes. Broad-spectrum products aim to offer the benefits of multiple cannabinoids while excluding THC, making them suitable for those sensitive to psychoactive effects. Understanding these differences is essential for healthcare professionals when recommending CBD products tailored to patient needs (Dawson et al., 2020).